(MedPage Today) — The FDA cleared a prescription smartphone app, dubbed LumosityRx, to help improve attention in adults with attention deficit-hyperactivity disorder (ADHD), maker Lumos Labs announced.
Teva Pharmaceutical submitted its once-monthly…
Source link : https://www.medpagetoday.com/psychiatry/generalpsychiatry/119067
Author :
Publish date : 2025-12-17 20:33:00
Copyright for syndicated content belongs to the linked Source.
